Table 2.

Multivariable Analyses for Remission in the GEMINI 2 Derivation Cohort

Independent Predictor*	OR†	Confidence Interval
Clinical Remission
No prior CD related hospitalization*	1.43	1.08,1.89
No baseline EIM	1.43	1.09, 1.88
No previous bowel surgery	1.49	1.12,1.98
No previous TNFα antagonist	2.18	1.65, 2.88
Baseline CRP	0.99	0.98, 1.00
Ethnicity (Other vs. Non-hispanic/Latino)	0.30	0.12, 0.75
Weighted 7-day liquid or very soft stool	0.99	0.99, 1.00
Baseline Albumin	1.04	1.01,1.08
Corticosteroid-Free Remission
No history of fistulizing disease	1.85	1.13, 3.03
No previous TNFα antagonist	1.80	1.16, 2.80
Baseline CRP	0.98	0.97, 1.00
Weighted 7-day liquid or very soft stool	0.99	0.99, 1.00
Sustained Clinical Remission
No history of fistulizing disease	1.82	1.22, 2.71
No previous bowel surgery	1.71	1.18, 2.49
No previous TNFα antagonist	1.42	1.01, 2.00
Baseline Albumin	1.07	1.04,1.10
Weighted 7-day liquid or very soft stool	0.995	0.99, 1.00

^*CD-related hospitalization within the previous 12 months.

CRP, C-reactive protein; OR, odds ratio; TNFα, tumor necrosis factor-alpha.